Skip to main content
. 2021 Mar 11;8(3):2334–2337. doi: 10.1002/ehf2.13284

Figure 1.

Figure 1

Proportion of patients adherent to each class of prescribed heart failure medication compared with the proportion of non‐adherent patients, patients not prescribed this medication class, or patients in which the medication class is contraindicated. ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor blocker–neprilysin inhibitor; BB, beta‐blocker; MRA, mineralocorticoid receptor antagonist.